1. A transnational perspective on the evolution of the synthetic cannabinoid receptor agonists market: Comparing prison and general populations. Issue 4 (28th January 2021) Authors: Norman, Caitlyn; Halter, Sebastian; Haschimi, Belal; Acreman, Dean; Smith, Josie; Krotulski, Alex J.; Mohr, Amanda L.A.; Logan, Barry K.; NicDaéid, Niamh; Auwärter, Volker; McKenzie, Craig Journal: Drug testing and analysis Issue: Volume 13:Issue 4(2021) Page Start: 841 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cumyl‐CBMICA: A new synthetic cannabinoid receptor agonist containing a cyclobutyl methyl side chain. Issue 1 (23rd October 2020) Authors: Halter, Sebastian; Pulver, Benedikt; Wilde, Maurice; Haschimi, Belal; Westphal, Folker; Riedel, Jan; Pütz, Michael; Schönberger, Torsten; Stoll, Stefanie; Schäper, Jan; Auwärter, Volker Journal: Drug testing and analysis Issue: Volume 13:Issue 1(2021) Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Detection and phase I metabolism of the 7‐azaindole‐derived synthetic cannabinoid 5F‐AB‐P7AICA including a preliminary pharmacokinetic evaluation. Issue 1 (23rd October 2019) Authors: Giorgetti, Arianna; Mogler, Lukas; Haschimi, Belal; Halter, Sebastian; Franz, Florian; Westphal, Folker; Fischmann, Svenja; Riedel, Jan; Pütz, Michael; Auwärter, Volker Journal: Drug testing and analysis Issue: Volume 12:Issue 1(2020) Page Start: 78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Development and validation of a rapid LC‐MS/MS method for the detection of 182 novel psychoactive substances in whole blood. Issue 2 (21st October 2021) Authors: Giorgetti, Arianna; Barone, Rossella; Pelletti, Guido; Garagnani, Marco; Pascali, Jennifer; Haschimi, Belal; Auwärter, Volker Journal: Drug testing and analysis Issue: Volume 14:Issue 2(2022) Page Start: 202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Extraordinary long detection window of a synthetic cannabinoid metabolite in human urine – Potential impact on therapeutic decisions. Issue 3 (4th February 2020) Authors: Franz, Florian; Haschimi, Belal; King, Leslie A.; Auwärter, Volker Journal: Drug testing and analysis Issue: Volume 12:Issue 3(2020) Page Start: 391 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Human phase‐I metabolism and prevalence of two synthetic cannabinoids bearing an ethyl ester moiety: 5F‐EDMB‐PICA and EDMB‐PINACA. Issue 3 (24th November 2022) Authors: Giorgetti, Arianna; Brunetti, Pietro; Haschimi, Belal; Busardò, Francesco Paolo; Pelotti, Susi; Auwärter, Volker Journal: Drug testing and analysis Issue: Volume 15:Issue 3(2023) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of legislation on NPS markets in Germany – The rise and fall of 5F‐ADB. Issue 6 (13th March 2020) Authors: Halter, Sebastian; Haschimi, Belal; Mogler, Lukas; Auwärter, Volker Journal: Drug testing and analysis Issue: Volume 12:Issue 6(2020) Page Start: 853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. New synthetic cannabinoids carrying a cyclobutyl methyl side chain: Human Phase I metabolism and data on human cannabinoid receptor 1 binding and activation of Cumyl‐CBMICA and Cumyl‐CBMINACA. Issue 8 (5th May 2021) Authors: Haschimi, Belal; Grafinger, Katharina Elisabeth; Pulver, Benedikt; Psychou, Evangelia; Halter, Sebastian; Huppertz, Laura M.; Westphal, Folker; Pütz, Michael; Auwärter, Volker Journal: Drug testing and analysis Issue: Volume 13:Issue 8(2021) Page Start: 1499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays. Issue 7 (21st May 2021) Authors: Grafinger, Katharina Elisabeth; Vandeputte, Marthe M.; Cannaert, Annelies; Ametovski, Adam; Sparkes, Eric; Cairns, Elizabeth; Juchli, Patrick Osamu; Haschimi, Belal; Pulver, Benedikt; Banister, Samuel D.; Stove, Christophe P.; Auwärter, Volker Journal: Drug testing and analysis Issue: Volume 13:Issue 7(2021) Page Start: 1412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The Novel Psychoactive Substance Cumyl-CH-MEGACLONE: Human Phase-I Metabolism, Basic Pharmacological Characterization and Comparison to Other Synthetic Cannabinoid Receptor Agonists with a γ-Carboline-1-One Core. Issue 3 (6th June 2020) Authors: Haschimi, Belal; Giorgetti, Arianna; Mogler, Lukas; Nagy, Tibor Zsigmond; Kramer, Selina; Halter, Sebastian; Boros, Sándor; Dobos, Adrienn; Hidvégi, Előd; Auwärter, Volker Journal: Journal of analytical toxicology Issue: Volume 45:Issue 3(2021) Page Start: 277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗